Our Mission

To pioneer healthtech in emerging markets, bringing innovative needs-based products to underserved populations in an impactful and sustainable way.

Neopenda is a public benefit corporation. As a social enterprise, we reinvest a majority of our profits to achieve sustainability, grow our reach, and ensure the fulfillment of our mission.

Our Journey

2015
Neopenda founded at Columbia University.
First needs assessment in Uganda.
Participated in Relevant Health Accelerator program.
2016
Initial non-dilutive fundraising.
Neopenda HQ moved to Chicago, IL.
User and market research in Uganda.
2017
Complete prototype system build.
Feedback from over 100 users in Uganda.
PCT patent filed.
2018
Opened office in Kampala, Uganda.
Participated in Techstars Chicago.
Named to MIT Solve Frontlines of Health class.
Clinical pilot study at Tufts Medical Center in Boston, MA.
2019
Raised seed funding round.
Clinical pilot study at Tufts Medical Center in Boston, MA.
Clinical pilot study at Jinja Regional Referral Hospital in Jinja, Uganda.
Design for Manufacturing of neoGuard™.
2020
Received regulatory approval in Kenya.
2021
Received CE Mark approval.
Entered the market in Kenya.
Annual Reports: 2018 2017 2016

Recognition